Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (LODR) Regulations 2015 ("Listing Regulations" we would like to inform you that based on the recommendation of the Nomination ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gennex Laboratories has appointed Mr. Sandeep Kumar Daga (DIN: 00860908) as an Additional Non-Executive Non-Independent Director, effective May 30, 2025. The appointment was recommended by the Nomination & Remuneration Committee and approved by the Board, subject to shareholder approval. Mr. Daga is a B.Com, ACA, ACS with over 30 years of experience in corporate management, marketing, and financial consultancy. He is not related to any existing Directors or Key Managerial Personnel, and is not part of the Promoter or Promoter Group.
This is a routine board-level addition and is unlikely to have a material impact on the stock price. Shareholders will get a chance to vote on his appointment, but no immediate operational change is signaled.